Prashant Tiwari (Author) Dr. Prashant Tiwari, Ph.D., is an Associate Professor in the Department of Pharmacology at the College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India. He holds a Ph.D. from Siksha O Anusandhan University, Bhubaneswar, and was a fellow of the Indian Council of Medical Research (ICMR), New Delhi. With over 13 years of experience in teaching and research, Dr.
Tiwari's expertise includes drug screening, method validation for brain-targeted drug delivery, drug-induced dyskinesia revalidation, and the neuroprotective effects of benzimidazole derivatives. His research has explored the dopaminergic pathway, prolactin inhibition, and neuroprotection, with notable studies on Nanoemulsions containing Lepidium sativum oil for Parkinson's disease and Muntingia Calabura leaf extract for Alzheimer's disease. For his outstanding work, Dr. Tiwari received the Dr. P. D. Patil National Award for Best Thesis in Pharmaceutical Sciences (2022). In addition to his research, Dr.
Tiwari has authored 5 books, edited 5 books, and co-authored 6 book chapters. He has filed 7 patents, 2 of which have been granted. He organized a national e-seminar on targeted drug delivery against neurodegenerative diseases, sponsored by the Department of Biotechnology (DBT), Government of India. Dr. Tiwari has been honored with various awards, including the ICMR Senior Research Fellowship, Young Scientist Award, and Best Teacher Award. He supervises 5 Ph.D. students and has guided 9 M.
Pharm students. He is also an active member of professional bodies and serves as a peer reviewer for international journals. His research interests span neurodegenerative disorders, drug interactions, pharmacokinetics/pharmacodynamics, and metabolic disorders. Sunil Kumar Kadiri (Author) Dr Sunil Kumar Kadiri is a Professor at the College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, Karnataka, with 16 years of teaching experience. His research interests encompass neuropharmacology, metabolic disorders, organ-protective activities, and drug interactions. He holds a Ph.D. in Pharmaceutical Sciences from JNTU Hyderabad and has authored 65 research and review articles.
In addition to publishing 5 books and 4 book chapters, he holds 6 patents. An active member of APTI, his recent research includes drug interaction studies involving Alprazolam and Pomegranate, Carbamazepine and Losartan, Naproxen and St. John's Wort, as well as investigations into the antiparkinsonian effects of Zinda Tilismath. Merugumolu Vijay Kumar (Author) Dr Merugumolu Vijay Kumar is a pharmacologist currently working as Associate Professor at the College of Pharmacy, Dayanand Sagar University, Bengaluru, Karnataka. With 12 years of experience, he is an active collaborator interested in conducting animal experiments in new models for pharmacological screening, developing labs for animal experimentation and animal housing facilities, and interdisciplinary research. He has published more than 35 articles in national and international journals and presented numerous papers at international and national conferences. Vijay was awarded the Young Scientist award at the Golden Global Health and Education International Conference held in 2019 in Dubai, and named one of the 100 Most Impactful Healthcare Leaders in the global listing unveiled in the same year in Mumbai.